(Q39727732)

14 September 2017

title

Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib (English)

1 reference

14 September 2017

1 reference

Chen Chen

1

1 reference

14 September 2017

Hui Ling Shen

2

1 reference

14 September 2017

Jing Yang

3

1 reference

14 September 2017

Qiao Yun Chen

4

1 reference

14 September 2017

Wen Lin Xu

5

1 reference

14 September 2017

publication date

14 March 2010

1 reference

Journal of Cancer Research and Clinical Oncology

14 September 2017

published in

1 reference

14 September 2017

volume

137

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

9-17

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-010-0854-3

14 September 2017

exact match

0 references

cites work

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-010-0854-3

The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin?

21 January 2018

1 reference

12 December 2020

The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line

1 reference

12 December 2020

Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels

1 reference

12 December 2020

NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells

1 reference

12 December 2020

Cell adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR.

1 reference

12 December 2020

Transcriptional regulators of the human multidrug resistance 1 gene: recent views

1 reference

12 December 2020

Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells

1 reference

12 December 2020

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise

1 reference

12 December 2020

Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer

1 reference

12 December 2020

Promoter hypermethylation silences cyclooxygenase-2 (Cox-2) and regulates growth of human hepatocellular carcinoma cells

1 reference

12 December 2020

Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation.

1 reference

12 December 2020

Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line

1 reference

12 December 2020

Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.

1 reference

12 December 2020

Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer

1 reference

12 December 2020

Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer.

1 reference

12 December 2020

Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells

1 reference

12 December 2020

Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells

1 reference

12 December 2020

Cyclooxygenase-2: potential role in regulation of drug efflux and multidrug resistance phenotype

1 reference

12 December 2020

Effect of the activated Raf protein kinase on the human multidrug resistance 1 (MDR1) gene promoter

1 reference

12 December 2020

Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells

1 reference

12 December 2020

Multidrug resistance transporters and modulation

1 reference

12 December 2020

Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer

1 reference

12 December 2020

Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors.

1 reference

12 December 2020

AP-1 function and regulation

1 reference

12 December 2020

CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells

1 reference

12 December 2020

ATP binding cassette transporters and drug resistance in breast cancer

1 reference

12 December 2020

10.1007/S00432-010-0854-3

Identifiers

DOI

1 reference

14 September 2017

1 reference